bioMérieux
A global leader in in vitro diagnostics for clinical and industrial applications.
BIM | PA
Overview
Corporate Details
- ISIN(s):
- FR0013280286 (+13 more)
- LEI:
- 549300AK8Y0LBIQ4T071
- Country:
- France
- Address:
- 376 CHE DE L'ORME, 69280 MARCY-L'ETOILE
- Website:
- https://www.biomerieux.com/
- Sector:
- Manufacturing
Description
bioMérieux is a global leader in the field of in vitro diagnostics, providing solutions that determine the source of disease and contamination. The company develops and manufactures diagnostic systems, reagents, and software for both clinical and industrial applications. In the clinical sector, its products are used for diagnosing infectious diseases, managing sepsis, combating antimicrobial resistance, and supporting cancer screening and cardiovascular emergencies. For industrial markets, bioMérieux offers microbiological control solutions to ensure the safety and quality of agri-food, pharmaceutical, and cosmetic products. These technologies provide rapid and reliable data to help healthcare professionals and industrial quality control managers make critical decisions that improve patient outcomes and ensure consumer safety.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2022-03-21 10:21 |
Mise à disposition du Document d’enregistrement universel incluant le rapport f…
|
French | PDF • 202.5 KB | ||
| 2022-03-18 07:01 |
bioMérieux receives FDA 510(k) clearance for its VITEK® MS PRIME new MALDI-TOF…
|
English | PDF • 475.0 KB | ||
| 2022-03-18 07:01 |
bioMérieux reçoit l’accréditation 510(k) de la FDA pour VITEK® MS PRIME, son n…
|
French | PDF • 488.6 KB | ||
| 2022-03-17 16:41 |
Document d'enregistrement universel
|
French | ZIP • 29.6 MB | ||
| 2022-03-17 16:41 |
Document d'enregistrement universel
|
French | ZIP • 29.6 MB | ||
| 2022-03-07 08:04 |
Février 2022 - Déclaration sur le nombre d'actions composant le capital social …
|
French | PDF • 204.8 KB | ||
| 2022-03-02 07:01 |
bioMérieux – 2021 Financial Results
|
English | PDF • 542.7 KB | ||
| 2022-03-02 07:01 |
bioMérieux – Résultats annuels au 31 décembre 2021
|
French | PDF • 560.5 KB | ||
| 2022-02-17 07:01 |
MYACUTECASE™, a free mobile application by bioMérieux to support clinicians in…
|
English | PDF • 404.3 KB | ||
| 2022-02-17 07:01 |
MYACUTECASE™, une application mobile gratuite de bioMérieux pour accompagner le…
|
French | PDF • 417.5 KB | ||
| 2022-02-03 10:19 |
Janvier 2022 - Déclaration sur le nombre d'actions composant le capital social …
|
French | PDF • 204.9 KB | ||
| 2022-01-10 10:20 |
Décembre 2021 - Déclaration sur le nombre d'actions composant le capital social…
|
French | PDF • 204.9 KB | ||
| 2021-12-14 07:01 |
Corporate Social Responsibility: bioMérieux recently received a series of offic…
|
English | PDF • 32.0 KB | ||
| 2021-12-14 07:01 |
Responsabilité Sociale d’Entreprise : bioMérieux a récemment obtenu une série d…
|
French | PDF • 32.0 KB | ||
| 2021-12-10 07:01 |
bioMérieux – Increased outlook for full-year 2021
|
English | PDF • 32.0 KB |
Automate Your Workflow. Get a real-time feed of all bioMérieux filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for bioMérieux
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for bioMérieux via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-09-04 | N/A | Other | Sell | 1,432 | 137,517.82 EUR |
| 2023-09-04 | N/A | Other | Sell | 1,253 | 120,328.10 EUR |
| 2023-09-01 | N/A | Other | Other | 2,900 | N/A |
| 2023-06-23 | N/A | Other | Other | 323 | 24,971.13 EUR |
| 2023-06-23 | N/A | Other | Buy | 323 | 24,971.13 EUR |
| 2023-06-23 | N/A | Other | Buy | 300 | 23,193.00 EUR |
| 2023-06-23 | N/A | Other | Buy | 25 | 1,932.75 EUR |
| 2023-03-23 | N/A | Other | Sell | 16,500 | 1,650,415.80 EUR |
Peer Companies
